Revving the CAR - Combination strategies to enhance CAR T cell effectiveness.
Sign Up to like & getrecommendations! Published in 2020 at "Blood reviews"
DOI: 10.1016/j.blre.2020.100695
Abstract: Chimeric antigen receptor (CAR) T cell therapy is currently approved for treatment of refractory B-cell malignancies. Response rates in these diseases are impressive by historical standards, but most patients do not have a durable response… read more here.
Keywords: car cell; revving car; combination strategies; car combination ... See more keywords